Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason R. Kelly currently holds 316,483 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason R. Kelly has been a net seller of DNA stock. They have purchased $0 and sold $45.2M worth of shares.
Jason R. Kelly's most recent insider trade was on Apr 9, 2026, when they sold 109,767 shares at $6.40 per share.
Jason R. Kelly serves as Executive at Ginkgo Bioworks Holdings, Inc. (DNA). They have executed 186 insider transactions totaling $45.2M over their tenure at the company.
Jason R. Kelly holds the position of Executive at Ginkgo Bioworks Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Jason R. Kelly has shown a selling trading pattern, with $0 in total purchases and $45.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason R. Kelly was on Apr 9, 2026, when they sold $702.2K worth of DNA shares. This transaction involved 109,767 shares at $6.40 per share.
Jason R. Kelly currently owns 316,483 shares of Ginkgo Bioworks Holdings, Inc. (DNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason R. Kelly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason R. Kelly has 186 Form 4 filings on record as an insider at Ginkgo Bioworks Holdings, Inc..
Set alerts for Jason R. Kelly and 40,000+ other insiders.